The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Caco-2 cell permeability assays to measure drug absorption
Abstract
Caco-2 cells are a human colon epithelial cancer cell line used as a model of human intestinal absorption of drugs and other compounds. When cultured as a monolayer, Caco-2 cells differentiate to form tight junctions between cells to serve as a model of paracellular movement of compounds across the monolayer. In addition, Caco-2 cells express transporter proteins, efflux proteins, and Phase II conjugation enzymes to model a variety of transcellular pathways as well as metabolic transformation of test substances. In many respects, the Caco-2 cell monolayer mimics the human intestinal epithelium. One of the functional differences between normal cells and Caco-2 cells is the lack of expression of the cytochrome P450 isozymes and in particular, CYP3A4, which is normally expressed at high levels in the intestine. However, Caco-2 cells may be induced to express higher levels of CYP3A4 by treatment with vitamin D3. Caco-2 cell monolayers are usually cultured on semipermeable plastic supports that may be fitted into the wells of multi-well culture plates. Test compounds are then added to either the apical or basolateral sides of the monolayer. After incubation for various lengths of time, aliquots of the buffer in opposite chambers are removed for the determination of the concentration of test compounds and the computation of the rates of permeability for each compound (called the apparent permeability coefficients). Although radiolabelled compounds were used in the original Caco-2 cells monolayer assays, radiolabelled compounds have been replaced in most laboratories by the use of liquid chromatography-mass spectrometry (LC-MS) and LC-tandem mass spectrometry (LC-MS-MS). Mass spectrometry not only eliminates the need for radiolabelled compounds, but permits the simultaneous measurement of multiple compounds. The measurement of multiple compounds per assay reduces the number of incubations that need to be carried out, thereby increasing the throughput of the experiments. Furthermore, LC-MS and LC-MS-MS add another dimension to Caco-2 assays by facilitating the investigation of the metabolism of compounds by Caco-2 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
Gottesman, M. M., & Pastan, I. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.002125 · Cited by 3,568
USSING, H. H., & ZERAHN, K. (1951) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1951.tb00800.x · Cited by 2,406
Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989) · Gastroenterology · doi:10.1016/s0016-5085(89)80072-1 · Cited by 2,396
Artursson, P., & Karlsson, J. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91647-u · Cited by 1,893
Artursson, P., Palm, K., & Luthman, K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00128-9 · Cited by 1,543
Kansy, M., Senner, F., & Gubernator, K. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970530e · Cited by 1,304 · cited 3×
“Recent studies have demonstrated good correlation between the flux in this system and the extent of absorption in humans for some well-characterised drugs [6,30].”
BackgroundYee, S. (1997) · Pharmaceutical Research · doi:10.1023/a:1012102522787 · Cited by 1,030
Artursson, P. (1990) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600790604 · Cited by 844
Paine, M. F., Khalighi, M., Fisher, J. M., Shen, D. D., Kunze, K. L., Marsh, C. L., Perkins, J. D., & Thummel, K. E. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37149-6 · Cited by 789
Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal Mucosa
Hilgers, A. R., Conradi, R. A., & Burton, P. S. (1990) · Pharmaceutical Research · doi:10.1023/a:1015937605100 · Cited by 587
Structural basis for physiological regulation of paracellular pathways in intestinal epithelia
Madara, J. L., & Pappenheimer, J. R. (1987) · The Journal of Membrane Biology · doi:10.1007/bf02209147 · Cited by 513
de Waziers, I., Cugnenc, P. H., Yang, C. S., Leroux, J. P., & Beaune, P. H. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12474-9 · Cited by 502
Lennernaäs, H. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970332a · Cited by 500
Watkins, P. B., Wrighton, S. A., Schuetz, E. G., Molowa, D. T., & Guzelian, P. S. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113156 · Cited by 480
Clark, S. L. (1959) · The Journal of Cell Biology · doi:10.1083/jcb.5.1.41 · Cited by 436
The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications
Meunier, V., Bourri�, M., Berger, Y., & Fabre, G. (1995) · Cell Biology and Toxicology · doi:10.1007/bf00756522 · Cited by 434
Carrier-Mediated Intestinal Transport of Drugs
Tsuji, A., & Tamai, I. (1996) · Pharmaceutical Research · doi:10.1023/a:1016086003070 · Cited by 392
Hunter, J., Jepson, M. A., Tsuruo, T., Simmons, N. L., & Hirst, B. H. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82429-2 · Cited by 370
CYP3A gene expression in human gut epithelium
Kolars, J. C., Lown, K. S., Schmiedlin-Ren, P., Ghosh, M., Fang, C., Wrighton, S. A., Merion, R. M., & Watkins, P. B. (1994) · Pharmacogenetics · doi:10.1097/00008571-199410000-00003 · Cited by 365
Schmiedlin-Ren, P., Thummel, K. E., Fisher, J. M., Paine, M. F., Lown, K. S., & Watkins, P. B. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.5.741 · Cited by 325
Human, Rat, and Mouse Metabolism of Resveratrol
Yu, C., Shin, Y. G., Chow, A., Li, Y., Kosmeder, J. W., Lee, Y. S., Hirschelman, W. H., Pezzuto, J. M., Mehta, R. G., & van Breemen, R. B. (2002) · Pharmaceutical Research · doi:10.1023/a:1021414129280 · Cited by 319
Self-citationCurrent methodologies used for evaluation of intestinal permeability and absorption
Balimane, P. V., Chong, S., & Morrison, R. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00113-1 · Cited by 319
The Use of Cultured Epithelial and Endothelial Cells for Drug Transport and Metabolism Studies
Audus, K. L., Bartel, R. L., Hidalgo, I. J., & Borchardt, R. T. (1990) · Pharmaceutical Research · doi:10.1023/a:1015800312910 · Cited by 267
Walle, U. K., Galijatovic, A., & Walle, T. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00133-1 · Cited by 251
Grès, M.-C., Julian, B., Bourrié, M., Meunier, V., Roques, C., Berger, M., Boulenc, X., Berger, Y., & Fabre, G. (1998) · Pharmaceutical Research · doi:10.1023/a:1011919003030 · Cited by 243
Wilson, G., Hassan, I. F., Dix, C. J., Williamson, I., Shah, R., Mackay, M., & Artursson, P. (1990) · Journal of Controlled Release · doi:10.1016/0168-3659(90)90118-d · Cited by 242
Strategies for Absorption Screening in Drug Discovery and Development
Bohets, H., Annaert, P., Mannens, G., van Beijsterveldt, L., Anciaux, K., Verboven, P., Meuldermans, W., & Lavrijsen, K. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394886 · Cited by 230
Transport mechanism and metabolism of olive oil hydroxytyrosol in Caco‐2 cells
Manna, C., Galletti, P., Maisto, G., Cucciolla, V., D'Angelo, S., & Zappia, V. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01350-8 · Cited by 211
Prueksaritanont, T., Gorham, L. M., Hochman, J. H., Tran, L. O., & Vyas, K. P. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07382-9 · Cited by 209
The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions
Yu, D. K. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922012006 · Cited by 199
Niessen, W. M. A. (2003) · Journal of Chromatography A · doi:10.1016/s0021-9673(03)00506-5 · Cited by 193
Assessing the Absorption of New Pharmaceuticals
Hidalgo, I. J. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013395010 · Cited by 190
Vaidyanathan, J. B., & Walle, T. (2001) · Pharmaceutical Research · doi:10.1023/a:1012200805593 · Cited by 184
Lennernäs, H., Nylander, S., & Ungell, A.-L. (1997) · Pharmaceutical Research · doi:10.1023/a:1012121632357 · Cited by 173
Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues.
McKinnon, R. A., Burgess, W. M., Hall, P. M., Roberts‐Thomson, S. J., Gonzalez, F. J., & McManus, M. E. (1995) · Gut · doi:10.1136/gut.36.2.259 · Cited by 169
Peptides and Related Drugs: A Review of Their Absorption, Metabolism, and Excretion
Humphrey, M., & Ringrose, P. S. (1986) · Drug Metabolism Reviews · doi:10.3109/03602538608998293 · Cited by 153
Kinetic Profiling of P-glycoprotein-Mediated Drug Efflux in Rat and Human Intestinal Epithelia
Stephens, R. H., O’Neill, C. A., Warhurst, A., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38782-8 · Cited by 149
Gan, L., Moseley, M. A., Khosla, B., Augustijns, P., Bradshaw, T., Hendren, R. W., & Thakker, D. R. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07353-2 · Cited by 144
Hu, M., Chen, J., & Lin, H. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.053496 · Cited by 142
The New Pre-Preclinical Paradigm: Compound Optimization in Early and Late Phase Drug Discovery
Caldwell, G. W., Ritchie, D. M., Masucci, J. A., Hageman, W., & Yan, Z. (2001) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026013394949 · Cited by 137
Lee, V. H. L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00163-9 · Cited by 129
Wang, Z., Hop, C. E. C. A., Leung, K., & Pang, J. (2000) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(200001)35:1<71::aid-jms915>3.0.co;2-5 · Cited by 103
Chong, S., Dando, S. A., & Morrison, R. A. (1997) · Pharmaceutical Research · doi:10.1023/a:1012112820371 · Cited by 98
Cytochromes P-450 in the intestinal mucosa of man
Peters, W. H. M., & Kremers, P. G. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90194-9 · Cited by 90
Ussing, H. H., & Zerahn, K. (1999) · PubMed · Cited by 83
Kramer, W., Girbig, F., Gutjahr, U., Kleemann, H., Leipe, I., Urbach, H., & Wagner, A. (1990) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(90)90043-n · Cited by 79
Evaluation of an accelerated Caco-2 cell permeability model
Liang, E., Chessic, K., & Yazdanian, M. A. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/(sici)1520-6017(200003)89:3<336::aid-jps5>3.0.co;2-m · Cited by 78
Fisher, J. M., Wrighton, S. A., Watkins, P. B., et al. (1999) · PubMed · Cited by 68
Intestinal responses to xenobiotics
Carrière, V., Chambaz, J., & Rousset, M. (2001) · Toxicology in Vitro · doi:10.1016/s0887-2333(01)00039-x · Cited by 55
Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures
Stevenson, C. L. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(98)00331-7 · Cited by 53
Barańczyk‐Kuźma, A., Garren, J. A., Hidalgo, I. J., & Borchardt, R. T. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90568-v · Cited by 49
Fung, E. N., Chu, I., Li, C., Liu, T., Soares, A., Morrison, R. A., & Nomeir, A. A. (2003) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1165 · Cited by 48
Compound mixtures in Caco-2 cell permeability screens as a means to increase screening capacity.
Tannergren, C., Langguth, P., & Hoffmann, K. J. (2001) · PubMed · Cited by 21
Combinatorial Approaches in Anticancer Drug Discovery: Recent Advances in Design and Synthesis
Bhattacharyya, S. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372139 · Cited by 12
Cited by
Samaranayaka, A. G. P., & Li-Chan, E. C. Y. (2011) · Journal of Functional Foods · doi:10.1016/j.jff.2011.05.006 · Cited by 789
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040883 · Cited by 531
Tam, J., Vemuri, V. K., Liu, J., Bátkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S. V., Pickel, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42551 · Cited by 454
Dima, C., Assadpour, E., Dima, S., & Jafari, S. M. (2020) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12623 · Cited by 304
Brown, T. D., Habibi, N., Wu, D., Lahann, J., & Mitragotri, S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.0c00743 · Cited by 182
Metadata
- Authors
- van Breemen, R. B., & Li, Y.
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa Healthcare
- Published
- 2005-08
- Volume
- 1
- Issue
- 2
- Pages
- 175-185
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2165711991
- Cited by
- 602
- References
- 55
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.